The effect of pretreatment with
CsCl on mice bearing
sarcoma I implants was studied as a function of
duration of treatment period, life span and tissue Cs+ and K+ levels. Treatment with
CsCl for 14 consecutive days prior to
sarcoma implantation resulted in initial reduction of the
tumor-mediated mortality compared to controls and to a one week pretreatment period with identical doses of
CsCl. A large accumulation of endogenous K+ was noted in
tumor mass compared to nonmalignant tissue of the same animals or to
tumor-free controls receiving identical Cs-treatment. The entry of exogenously administered Cs+ into malignant tissue was less than that accumulating in respective controls. The accumulation of Cs+ in
tumor mass was dose-dependent. The ratio of K+:C+ was greater in
tumor tissue than in nonmalignant tissue. The results suggest that a critical balance between these
alkali metals may be required for adequate Cs effect against the
tumor studied.